Facebook
Twitter
LinkedIn
ForwardCaring for Kids with Cancer Symposium - International Webcast
This symposium will highlight a spectrum of new developments and innovative advances in current pediatric oncology practice. The faculty — including leading experts from the top local and national cancer care institutions — will review the latest technologies and therapeutic approaches to challenging clinical problems, and will focus on evidence-based approaches to the special physical, emotional and psychological needs of pediatric cancer patients and their families.
Working in partnership to provide the best possible care for the communities they serve, two local leaders in healthcare – Miami Cancer Institute, part of Baptist Health South Florida, the area's largest, not-for-profit healthcare provider, and nonprofit Nicklaus Children's Hospital, part of Miami Children's Health System and the leading provider of children's healthcare services in South Florida – are collaborating to improve healthcare through continuing education.
Complete details at MiamiCancerInstitute.com/CaringforKids
Target Audience
Pediatricians, Pediatric Oncologists, Hematologists/Oncologists, Infectious Disease Pediatricians, Pediatric General Internists, Family Physicians, Neonatologists, ED Physicians, Psychiatrists, Psychologists, Nurses, Respiratory Therapists, and all interested healthcare providers who care for children with cancer.
Learning Objectives
- Describe and be familiar with current T-cell therapy approaches.
- Examine and have a better understanding on how T-cells are generated and currently used in the clinic.
- Analyze challenged and opportunities in developing T-cell therapies for pediatric cancer.
- Summarize the meaning and use of histologic necrosis following initial chemotherapy in the treatment of osteosarcoma.
- Describe the evolving role of genomic profiling in the diagnosis and treatment of osteosarcoma.
- Implement intraoperative MRI, computed tomography and ultrasound to maximize the extent of tumor resection in a single sitting.
- Describe intraoperative neurophysiological monitoring that has been successful to assist in the safe remover of tumors in eloquent areas of the brain.
- Describe selected pediatric cancer diagnosis and associated nutrition risks and complications.
- Identify caregivers who would benefit from nutrition referral to assist with nutrition care planning responsibilities during selected treatment roadmaps.
- Discuss available nutrition guidelines and best practice for the pediatric cancer patient survivor.
- Apply tumor precision diagnostics in order to improve patient care.
- Assess molecular studies that have led to the identification of distinct tumor subgroups in pediatric brain tumors.
- Describe current CD19 CAR T-cell therapy outcomes and limitations.
- Assess and familiarize the onset, optimal management and results of anti-tumor efficacy of CAR T-cell toxicities.
- Describe the value of dose intensity in the treatment of newly diagnosed EWING sarcoma.
- Analyze the controversy around the use of high dose therapy with autologous stem cell support in the treatment of Ewing sarcoma.
- Describe robotic surgery in pediatric cancer care.
- Analyze potential usage of robotic surgery in pediatric cancer.
- Demonstrate pediatric cancer surgery case presentations
- Identify selected pediatric cancer diagnosis and associated nutrition risks and complications.
- Discuss nutrition risks associated with pediatric cancer.
- Discuss common nutrition diagnosis associated with pediatric cancer treatment modalities.
7:30 – 7:50 a.m. Registration and Breakfast
7:50 a.m. Welcome and Introductions
8:00 a.m. Immunotherapy in Pediatric Tumors - Stephen Gottschalk, M.D.
8:45 a.m. Osteosarcoma Update - Paul A. Meyers, M.D.
9:10 a.m. Questions and Answers - Stephen Gottschalk, M.D. and Paul A. Meyers, M.D.
9:25 a.m. Update on Neurosurgical Advances in Pediatric Tumors - Toba N. Niazi, M.D.
9:50 a.m. Pediatric Nutrition and Oncology - Dominique Symonette, M.S., RDN
10:15 a.m. Questions and Answers - Toba N. Niazi, M.D. and Dominique Symonette, M.S., RDN
10:30 a.m. Break and Visit Exhibits
10:50 a.m. Molecular Classification of Brain Tumors - Michael D. Taylor, M.D., Ph.D.
11:35 a.m. CAR T Cells for Solid Tumors: What are the Challenges? - Stephen Gottschalk, M.D.
12:00 p.m. Questions and Answers - Michael D. Taylor, M.D., Ph.D. and Paul A. Meyers, M.D.
12:15 p.m. Break and Exhibits
12:35 p.m. Ewing Sarcoma Update - Paul A. Meyers, M.D.
1:00 p.m. Robotics as enhancement to cancer surgery in children - Faud Alkhoury, M.D.
1:25 p.m. Managing Treatment Side Effects and Maintaining Proper Nutrition - Dominique Symonette, M.S., RDN
1:50 p.m. Questions and Answers - Paul A. Meyers, M.D., Toba N. Niazi, M.D. and Dominique Symonette, M.S., RDN
2:05 p.m. Adjourn
Symposium Directors:
Doured Daghistani, M.D.
Symposium Director
Hematology/Oncology
Baptist, Homestead, South Miami Hospitals
Miami, Florida
Doured Daghistani, M.D., has indicated that neither he nor his spouse/partner have relevant financial relationships with commercial interest companies, and he will not include off-label or unapproved product usage in his presentation(s) or discussion(s).
Ziad Khatib, MD
Director of Medical Neuro-Oncology
Division of Pediatric Hematology Oncology
Clinical Associate Professor
Department of Pediatrics
Florida International University
Kidz Medical Services
Nicklaus Children’s Hospital
Miami, Florida
Ziad Khatib, M.D., has indicated that neither he nor his spouse/partner have relevant financial relationships with commercial interest companies, and he will not include off-label or unapproved product usage in his presentation(s) or discussion(s).
Symposium Faculty:
Fuad Alkhoury, M.D.
Director, Neonatal General Surgery
Niklaus Children’s Hospital
Miami, Florida
Faud Alkhoury, M.D. indicated that neither he nor his spouse/partner has relevant financial relationships with commercial interest companies, and he will not include off-label or unapproved product usage in his presentation(s) or discussion(s).
Stephen Gottschalk, M.D.
Chair, Department of Bone Marrow Transplantation and Cellular Therapy
Endowed Chair in Bone Marrow Transplantation and Cellular Therapy
St. Jude’s Children’s Hospital
Memphis, Tennessee
Stephen Gottschalk, M.D. indicated that neither he nor his spouse/partner has relevant financial relationships with commercial interest companies, and he will not include off-label or unapproved product usage in his presentation(s) or discussion(s).
Paul A. Meyers, M.D.
Pediatric Oncologist
Chief of Sarcoma Service
Vice Cahir for Clinical Affairs
Memorial Sloan Kettering
New York, New York
Paul A. Meyers, M.D. indicated that neither he nor his spouse/partner has relevant financial relationships with commercial interest companies, and he will not include off-label or unapproved product usage in his presentation(s) or discussion(s).
Toba N. Niazi, M.D.
Pediatric Neurosurgeon
Nicklaus Children’s Hospital
Miami, Florida
Toba Niazi, M.D. indicated that neither he nor his spouse/partner has relevant financial relationships with commercial interest companies, and he will not include off-label or unapproved product usage in his presentation(s) or discussion(s).
Dominique Symonette, M.S., RDN. LDN, CNSC
Clinical Nutritionist Specialist
Miami Cancer Institute
Miami, Florida
Dominique Symonette, M.S., indicated that neither he nor his spouse/partner has relevant financial relationships with commercial interest companies, and he will not include off-label or unapproved product usage in his presentation(s) or discussion(s).
Michael D. Taylor M.D., Ph.D.
Staff Neurosurgeon, Hospital for Sick Children
Professor, Department of Surgery and,
Department of Laboratory Medicine and Pathobiology
University of Toronto
Toronto, Canada
Michael D. Taylor, M.D., indicated that neither he nor his spouse/partner has relevant financial relationships with commercial interest companies, and he will not include off-label or unapproved product usage in his presentation(s) or discussion(s).
Non-faculty contributors and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose.
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this live activity for a maximum of 5.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been approved for 5.5 credit hours by the Florida Boards of Medicine, Osteopathic Medicine and the Florida Council of Physician Assistants. CE Broker #20-726676 .
Approved for a total of 5.5 contact hours by the Florida State Board of Nursing and Respiratory Therapy. CE Broker Provider #50-182.
Additional credits pending.
Available Credit
- 5.50 AMA PRA Category 1 Credit™
- 5.50 General certificate of attendance
- 5.50 Nurse Practitioners
- 5.50 Florida Board of Nursing
- 5.50 Florida Board of Psychology
- 5.50 Florida Board of Respiratory Therapy
Required Hardware/Software
If you are not able to register, please look in the upper right to see if there is something in your shopping cart.
Technical Support: If you are experiencing technical difficulties or have received an error message, please send an email to CME@BaptistHealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours.